IGF2BP3 and malignant colon neoplasm: And some studies have shown that the knockout of IGF2BP3 can inhibit DNA replication and angiogenesis in the S phase of the cell cycle by reading the m6A modification of CCND1 and vascular endothelial growth factor (VEGF) respectively in colon cancer (28).